SCPHARMACEUTICALS INC has a total of 17 patent applications. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals are HARVARD SCIENT CORP, CAVE HAROLD GORDON and LA PHARMATECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Hong Kong | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Muntendam Pieter | 14 |
#2 | Michaels Scott A | 10 |
#3 | Larsen Glenn R | 9 |
#4 | Glenn R Larsen | 2 |
#5 | Scott A Michaels | 2 |
#6 | Pieter Muntendam | 2 |
#7 | Grossi Alfredo | 1 |
#8 | Kostraba Britt | 1 |
#9 | Koppenhagen Franciscus | 1 |
#10 | Ogunleye Olatokumbo O Luca | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020160210A1 | Concentrated liquid pharmaceutical formulations of furosemide and methods of administering the same | |
AU2015364677A1 | Triphasic dosing regimens for the administration of time-dependent antibiotics and devices for the same | |
MX2015014064A | Pharmaceutical formulations for subcutaneous administration of furosemide. | |
EP2978441A2 | Combination therapy for subcutaneous administration of glycopeptide antibiotics |